Почетна › Steatotna bolest jetre › Misuri
Kliničke studije za Steatotna bolest jetre u državi Misuri
13 studija za Steatotna bolest jetre traži učesnike na lokacijama u državi Misuri.
Gradovi u državi Misuri
Zvanični tekst studije (na engleskom)
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Columbia
- Akero Clinical Study Site, Kansas City
- Akero Clinical Study Site, St Louis
- и још 1
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06528314A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Gastrointestinal Associates, Columbia
- Gateway GI Research, LLC, St Louis
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT07288138A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Kansas City
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT06920043A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, St Louis
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07704892A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
- GSK Investigational Site, St Louis
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07701993A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, St Louis
- 89bio Clinical Study Site, St Louis
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, St Louis
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT06318169A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- AMR Clinical, Kansas City
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07165028A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
- GSK Investigational Site, Springfield
- GSK Investigational Site, St Louis
- GSK Investigational Site, St Louis
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 17. 9. 2026. · NCT07221188Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)
- University of Missouri School of Medicine, Columbia
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 18 до 70 · Оба пола · Ажурирано 6. 8. 2026. · NCT06571474Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
- University of Missouri School of Medicine, Columbia
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 70 · Оба пола · Ажурирано 6. 8. 2026. · NCT06335771A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Kansas City
- GSK Investigational Site, Springfield
- GSK Investigational Site, St Louis
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 7. 2026. · NCT07221227Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
- Harry S. Truman Memorial, Columbia, MO, Columbia
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 19. 2. 2026. · NCT05526144Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.